tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
Holding LXRX?
Track your performance easily

Lexicon Pharmaceuticals (LXRX) Financial Statements

1,410 Followers

Lexicon Pharmaceuticals Financial Overview

Lexicon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.745; its P/E ratio is -1.16; Lexicon Pharmaceuticals is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.75M$ 1.65M$ 317.00K$ 24.00K-
Gross Profit$ 1.68M$ 1.48M$ 309.00K$ 24.00K-
EBIT$ -64.81M$ -53.43M$ -44.90M$ -31.93M-
EBITDA$ -64.28M$ -52.77M$ -44.49M$ -31.56M-
Net Income Common Stockholders$ -64.81M$ -53.43M$ -44.90M$ -31.93M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 258.37M$ 309.96M$ 256.74M$ 105.94M$ 138.36M
Total Assets$ 321.12M$ 373.36M$ 316.90M$ 162.72M$ 194.30M
Total Debt$ 99.90M$ 99.50M$ 98.77M$ 48.84M$ 0.00
Net Debt$ -158.47M$ -210.46M$ -157.97M$ -57.09M$ -138.36M
Total Liabilities$ 142.61M$ 133.38M$ 130.36M$ 74.67M$ 77.17M
Stockholders Equity$ 178.51M$ 239.98M$ 186.36M$ 88.05M$ 117.12M
Cash Flow-
Free Cash Flow$ -53.93M$ -48.79M$ -38.26M$ -31.86M-
Operating Cash Flow$ -53.62M$ -48.54M$ -38.12M$ -31.61M-
Investing Cash Flow$ 53.47M$ -12.32M$ -74.61M$ 12.09M-
Financing Cash Flow$ -916.00K$ -14.00K$ 189.00M$ -824.00K-
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

Lexicon Pharmaceuticals Debt to Assets

Lexicon Pharmaceuticals Cash Flow

Lexicon Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis